Business
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
- Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1) - The
About this update from Accuray Incorporated
[{"type":"text","content":"- Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1)\n - The approval expands global patient access to the CyberKnife System, an effective, non-invasive treatment alternative to surgery\n\n\nSUNNYVALE, Calif., Dec. 15, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market the CyberKnife® Robotic Radiosurgery System for the treatment of trigeminal neuralgia (TN) in Japan. The system is currently used to treat TN in the U.S., EIMEA and other parts of the world. With the Shonin approval, more TN patients will have access to a high-precision radiosurgery treatment typically delivered in just one out-patient procedure.\n\n \n \n \n \n \n \n\n \n\"It is with great pride that we announce the expansion of the CyberKnife System's approved indications for use in Japan to now include trigeminal neuralgia. This approval reinforces our team's dedication to providing our customers with innovative products that expand the potential to use radiation in a new field of application, enabling them to enhance the quality of patient care and improve the patient experience. The system provides a proven, non-surgical option for treating trigeminal neuralgia without a fixed frame that must be secured to the patient's head to prevent movement, as required with other devices,\" said Suzanne Winter, president of Accuray.\nTN is a chronic pain condition that affects the trigeminal nerve which carries sensation from the face to the brain. Patients can experience excruciating pain in the areas of the face where the branches of the nerve are distributed including the upper and lower jaws, scalp, forehead, eyes, nose and lips. TN occurs most frequently in people over age 50 and is more common in women than in men2.\nPeople diagnosed with TN require long-term medical care that usually begins with medication to block the pain signals sent to the brain. Over time, however, some medications become less effective, or patients experience unpleasant side effects. For these patients, injections, surgery or radiosurgery may be required.\nData indicate stereotactic radiosurgery (SRS) treatments delivered with the CyberKnife System result in rapid and long-la...